Is There a Role for Multiple Lines of Anti-HER2 Therapies Administered Beyond Progression in HER2-Mutated Non-Small Cell Lung Cancer? A Case Report and Literature Review
Crossref DOI link: https://doi.org/10.1007/s40487-020-00121-5
Published Online: 2020-07-07
Published Print: 2020-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Metro, Giulio https://orcid.org/0000-0002-4978-9212
Baglivo, Sara
Moretti, Riccardo
Bellezza, Guido
Sidoni, Angelo
Roila, Fausto
Text and Data Mining valid from 2020-07-07
Version of Record valid from 2020-07-07
Article History
Received: 18 May 2020
First Online: 7 July 2020